Related Experiment Video

Updated: Apr 24, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

8.9K

Structural studies on mechanisms to activate mutant p53

Hector Viadiu1, Gilberto Fronza, Alberto Inga

  • 1Instituto de Química, Universidad Nacional Autónoma de México (UNAM), Mexico City, D.F., Mexico, viadiu@unam.mx.

Sub-Cellular Biochemistry
|September 10, 2014
PubMed

Insights

Developing a broad-spectrum cancer drug targeting the p53 tumor suppressor is crucial. Structural studies aim to reactivate mutant p53 by understanding its atomic details for rational drug design.

Area of Science:

  • Oncology
  • Structural Biology
  • Drug Discovery

Background:

  • Most cancers involve mutations in the p53 tumor suppressor gene, leading to inactive p53 protein.
  • p53 is a critical target for developing broad-spectrum cancer therapeutics.
  • Restoring p53 activity holds significant clinical potential for cancer treatment.

Purpose of the Study:

  • To review mechanisms influencing p53 activity.
  • To provide structural insights for rationally designing drugs that reactivate mutant p53.
  • To guide the development of novel cancer therapies targeting p53.

Main Methods:

  • Review of structural studies on mutant p53.
  • Analysis of mechanisms affecting p53 activity.
  • Identification of strategies for mutant p53 reactivation.

Main Results:

  • Three key mechanisms influencing p53 activity are reviewed.
  • Strategies for mutant p53 reactivation include stabilizing active conformations, suppressing mutations, and enhancing transactivation.
  • Atomic information is crucial for rational drug design targeting mutant p53.

Conclusions:

  • Targeting mutant p53 is a promising strategy for broad-spectrum cancer drug development.
  • Structural studies provide essential atomic details for designing p53-reactivating drugs.
  • Reactivating p53 offers a pathway to significant clinical benefits for cancer patients.

More Related Videos

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

358
Exploring Caspase Mutations and Post-Translational Modification by Molecular Modeling Approaches05:56

Exploring Caspase Mutations and Post-Translational Modification by Molecular Modeling Approaches

Published on: October 13, 2022

1.5K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
8.2K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.6K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
2.3K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
8.5K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
32.1K